Zentalis Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Zentalis Pharmaceuticals

28/02/2024 16:37

* Zentalis Pharmaceuticals Inc  ZNTL.OQ  reported a
quarterly
adjusted loss of 93 cents​​ per share for the quarter ended in
December, lower than the same quarter last year, when the
company reported EPS of -92 cents.  The mean expectation of
eleven analysts for the quarter was for a loss of 92 cents per
share. Wall Street expected results to range from $-1.54 to -61
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Zentalis Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 93 cents​.
    * The company reported a quarterly loss of $60.92 million.
    * Zentalis Pharmaceuticals Inc shares had fallen by 2.9%
this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Zentalis
Pharmaceuticals Inc is $37.00 
This summary was machine generated from LSEG data February 28 at
04:36 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.92          -0.93          Missed
 Sep. 30 2023      -0.91          -0.79          Beat
 Jun. 30 2023      -1.04          -1.85          Missed
 Mar. 31 2023      -1.02          -1.07          Missed